Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins
- PMID: 2079636
- DOI: 10.3109/14756369009035837
Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins
Abstract
Eight different di- and tripeptidyl aldehyde derivatives, each having at its C-terminus an aldehyde analog of L-norleucine, L-methionine, or L-phenylalanine with a preceding L-leucine residue, were synthesized and tested for their inhibitory effects on several serine and cysteine endopeptidases. These compounds showed almost no inhibition of trypsin, and only weak inhibition of alpha-chymotrypsin and cathepsin H, while they exhibited marked inhibition of cathepsin B less than calpain II congruent to calpain I less than cathepsin L, being stronger in this order. The mode of inhibition of these cysteine proteinases was competitive for the peptide substrate used and inhibitor constants (Ki) were calculated from the Dixon plot. The best inhibitors found were: 4-phenyl-butyryl-Leu-Met-H for calpain I (Ki, 36 nM) and calpain II (Ki, 50 nM); acetyl-Leu-Leu-nLeu-H for cathepsin L (Ki, 0.5 nM); acetyl-Leu-Leu-Met-H for cathepsin B (Ki, 100 nM).
Similar articles
-
The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B.Biochem J. 1988 Aug 1;253(3):751-8. doi: 10.1042/bj2530751. Biochem J. 1988. PMID: 2845932 Free PMC article.
-
Peptide alpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors of calpains and other cysteine proteases.J Med Chem. 1993 Oct 29;36(22):3472-80. doi: 10.1021/jm00074a031. J Med Chem. 1993. PMID: 8230139
-
Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases.J Med Chem. 1996 Sep 27;39(20):4089-98. doi: 10.1021/jm950541c. J Med Chem. 1996. PMID: 8831774
-
Low-molecular-weight aldehyde inhibitors of cathepsin G.Protein Pept Lett. 2009;16(4):408-10. doi: 10.2174/092986609787848144. Protein Pept Lett. 2009. PMID: 19356138
-
Biogenic Aldehydes as Therapeutic Targets for Cardiovascular Disease.Curr Opin Pharmacol. 2017 Apr;33:56-63. doi: 10.1016/j.coph.2017.04.004. Epub 2017 May 18. Curr Opin Pharmacol. 2017. PMID: 28528297 Free PMC article. Review.
Cited by
-
Cathepsin B Dependent Cleavage Product of Serum Amyloid A1 Identifies Patients with Chemotherapy-Related Cardiotoxicity.ACS Pharmacol Transl Sci. 2019 Aug 12;2(5):333-341. doi: 10.1021/acsptsci.9b00035. eCollection 2019 Oct 11. ACS Pharmacol Transl Sci. 2019. PMID: 32259067 Free PMC article.
-
Limitations of SLLVY-AMC in calpain and proteasome measurements.Biochem Biophys Res Commun. 2008 Jul 4;371(3):578-81. doi: 10.1016/j.bbrc.2008.04.133. Epub 2008 May 5. Biochem Biophys Res Commun. 2008. PMID: 18457661 Free PMC article.
-
Potential drug discovery for COVID-19 treatment targeting Cathepsin L using a deep learning-based strategy.Comput Struct Biotechnol J. 2022;20:2442-2454. doi: 10.1016/j.csbj.2022.05.023. Epub 2022 May 17. Comput Struct Biotechnol J. 2022. PMID: 35602976 Free PMC article.
-
Mitochondrial micro-calpain is not involved in the processing of apoptosis-inducing factor.Exp Neurol. 2009 Aug;218(2):221-7. doi: 10.1016/j.expneurol.2009.04.013. Epub 2009 Apr 23. Exp Neurol. 2009. PMID: 19393648 Free PMC article.
-
Proteasome inhibitors prevent tracheary element differentiation in zinnia mesophyll cell cultures.Plant Physiol. 1998 Oct;118(2):419-30. doi: 10.1104/pp.118.2.419. Plant Physiol. 1998. PMID: 9765527 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous